S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
Log in
NYSE:USPH

U.S. Physical Therapy Stock Forecast, Price & News

$127.82
-2.69 (-2.06 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$127.04
Now: $127.82
$131.67
50-Day Range
$105.42
MA: $118.02
$130.51
52-Week Range
$45.13
Now: $127.82
$134.11
Volume65,279 shs
Average Volume62,848 shs
Market Capitalization$1.64 billion
P/E Ratio53.26
Dividend Yield0.25%
Beta1.22
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of October 9, 2020, it operated 549 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
U.S. Physical Therapy logo

MarketRank

Overall MarketRank

1.36 out of 5 stars

Medical Sector

492nd out of 1,480 stocks

Health Services Industry

3rd out of 6 stocks

Analyst Opinion: 1.2Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000
Employees3,200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$481.97 million
Cash Flow$5.47 per share
Book Value$18.92 per share

Profitability

Net Income$40.04 million

Miscellaneous

Market Cap$1.64 billion
Next Earnings Date2/25/2021 (Estimated)
OptionableOptionable
$127.82
-2.69 (-2.06 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

How has U.S. Physical Therapy's stock price been impacted by COVID-19 (Coronavirus)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, USPH stock has increased by 37.1% and is now trading at $127.82.
View which stocks have been most impacted by COVID-19
.

Is U.S. Physical Therapy a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" U.S. Physical Therapy stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USPH, but not buy additional shares or sell existing shares.
View analyst ratings for U.S. Physical Therapy
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than U.S. Physical Therapy?

Wall Street analysts have given U.S. Physical Therapy a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but U.S. Physical Therapy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for U.S. Physical Therapy
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its quarterly earnings results on Thursday, November, 5th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.51 by $0.35. The firm had revenue of $108.93 million for the quarter, compared to the consensus estimate of $103.43 million. U.S. Physical Therapy had a net margin of 6.64% and a return on equity of 13.36%. U.S. Physical Therapy's quarterly revenue was down 7.1% on a year-over-year basis. During the same period last year, the company posted $0.71 EPS.
View U.S. Physical Therapy's earnings history
.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Friday, February 28th. Shareholders of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 annualized dividend and a yield of 1.00%. The ex-dividend date is Thursday, March 12th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.30.
View U.S. Physical Therapy's dividend history
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $0.32 per share and currently has a dividend yield of 0.25%. The dividend payout ratio of U.S. Physical Therapy is 11.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 12.03% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What price target have analysts set for USPH?

3 brokerages have issued twelve-month price targets for U.S. Physical Therapy's stock. Their forecasts range from $80.00 to $100.00. On average, they anticipate U.S. Physical Therapy's share price to reach $90.00 in the next twelve months. This suggests that the stock has a possible downside of 29.6%.
View analysts' price targets for U.S. Physical Therapy
or view Wall Street analyst' top-rated stocks.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 56, Pay $1.3M)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 63, Pay $804.07k)
  • Mr. Graham D. Reeve M.B.A., P.T., Chief Operating Officer of East (Age 56, Pay $793.34k)
  • Mr. Carey P. Hendrickson, Chief Financial Officer (Age 58)
  • Mr. Richard S. Binstein, Gen. Counsel & Sec.
  • Mr. Jon C. Bates, VP & Corp. Controller
  • Johnny J. Blanchard, Assistant Controller

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (2.89%), Scout Investments Inc. (0.72%) and State of Alaska Department of Revenue (0.08%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy
.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy
or view top insider-selling stocks.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was purchased by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, and Scout Investments Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy
or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $127.82.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.64 billion and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 3,200 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.